Syneos Health is a holding company. Through its subsidiaries, Co. is an integrated biopharmaceutical solutions organization. Co.'s segments are: Clinical Solutions, which provides services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, and clinical monitoring; and Commercial Solutions, which provides commercialization services, including deployment solutions, communication solutions (public relations, advertising, and medical communications), and consulting services. The SYNH average annual return since 2014 is shown above.
The Average Annual Return on the SYNH average annual return since 2014 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SYNH average annual return since 2014 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SYNH average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|